바이오칩 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 기술별, 유형별, 용도별, 최종사용자별, 지역별 부문, 경쟁(2020-2030년)

Global Biochip Market was valued at USD 15.82 billion in 2024 and is expected to reach USD 35.65 billion in the forecast period with a CAGR of 14.46% through 2030. Biochips are miniature medical devices designed to perform multiple biochemical reactions simultaneously, reducing the required time. They consist of micro-test sites or microarrays arranged on a solid substrate. Biochips are available in various forms, including DNA, protein, enzyme, and lab-on-a-chip. These compact and powerful devices are user-friendly and provide accurate critical insights. They are particularly suitable for storing personal medical and financial information and can be used for tracking individuals. Implanted in the body, biochips assist in monitoring, analyzing, and controlling patient health and biological processes. Additionally, they contribute to hazard identification, ensuring a safe environment, and improving decision-making. Consequently, biochips have widespread applications in gene, oncology, and inflammatory diagnosis, as well as molecular analysis worldwide.

The growing demand for personalized medicine and rapid diagnostics is significantly fueling the adoption of biochips across healthcare and research sectors. With advancements in genomics, proteomics, and microfluidics, biochips are becoming essential tools for detecting genetic disorders, cancer biomarkers, and infectious diseases at an early stage. Their ability to deliver high-throughput, multiplexed data from a single sample makes them indispensable in both clinical and laboratory settings. Moreover, the integration of artificial intelligence and cloud computing is further enhancing biochip performance by enabling real-time data analysis, pattern recognition, and predictive diagnostics, ultimately improving patient outcomes and healthcare efficiency.

Key Market Drivers

Growing Use of Biochips in Personalized Medicine

Biochips are revolutionizing point-of-care and molecular diagnostics, fueling their tremendous uptake in personalized medicine. They enable clinicians to distinguish between healthy and malignant cells with unprecedented speed and accuracy. Industry data show that over 65% of cancer therapy protocols now incorporate biochip-based diagnostics to identify cell surface markers. Their capacity for whole-proteome analysis using minimal sample volume has transformed protein-based drug development, leading to 40% faster turnaround in therapeutic evaluations across research labs.

Their importance at the point of care is underscored by their performance in rapid diagnostic settings-over 70% of emerging POC diagnostic tools launched in 2024 utilize biochips. These compact devices support diagnosis with a tiny blood or tissue sample, accelerating decision-making in oncology, autoimmune disorders, and metabolic diseases. They also reduce patient burden by avoiding larger invasive sampling, making them ideal for chronic-condition monitoring. Healthcare providers increasingly rely on biochips for real-time biomarker detection, particularly in outpatient or remote-care environments.

A notable advantage is the precise detection of multiple biomarkers from a single sample without compromising accuracy. Recent evaluations demonstrate biochip assays achieving over 95% sensitivity and specificity in identifying protein biomarkers linked to breast, colon, and lung cancers. This high reliability empowers clinicians to design individualized treatment plans and adjust therapies based on a patient's molecular signature. As precision medicine initiatives expand, the integration of biochips with AI-driven analytics offers even richer insights, helping to predict treatment response and patient outcomes more effectively.

Key Market Challenges

High Chances of Biohacking and Privacy Concern

Biochips, tiny devices inserted into the hands, have revolutionized daily routines by expediting tasks. These cutting-edge chips offer a multitude of benefits, such as seamless access to homes, gyms, and offices, along with the convenience of storing emergency contacts, social media profiles, and e-tickets. Notably, Sweden has witnessed a surge in individuals opting to have these microchips implanted in their hands. However, scientists have raised concerns regarding potential data breaches and hacking vulnerabilities associated with biochips. These chips have the capability to track locations, monitor spending habits, and even record driving behaviors, making them susceptible to unauthorized access. Moreover, the presence of chips inside the body poses infection risks and raises questions about individual freedom. In response to these concerns, the United States has recently implemented regulations to prohibit the forced usage of biochips. It is anticipated that the market's revenue growth may face constraints due to the risks of biohacking and privacy concerns. The need for enhanced security measures and addressing privacy issues is crucial for the sustainable growth of this innovative industry.

Key Market Trends

Increasing Adoption of Biochips For Detecting Allergies

Many individuals have encountered various types of allergies, such as food, pollen, and others, resulting in a range of symptoms including fever, skin reactions, vomiting, asthma, and diarrhea. To address these issues, the field of allergy testing has witnessed the emergence of a remarkable new technology known as allergy testing biochips. This technology is currently experiencing significant growth and involves the use of microarrays that contain different allergen components. By utilizing these biochips, healthcare professionals are able to investigate patient-specific sensitization patterns in a single measurement, thus enhancing the accuracy and efficiency of allergy diagnoses.

Furthermore, the potential of biochips in allergy research has prompted companies to invest in the development of new technologies. For example, in April 2021, Toray Industries made an announcement regarding the successful development of allergy testing biochips capable of detecting multiple allergen-specific immunoglobin E (IgE) antibodies from trace amounts of blood. This breakthrough innovation holds tremendous promise for improving the precision and effectiveness of allergy testing.

The increasing adoption of biochips for detecting and testing allergens is expected to be a major driver for revenue growth in the allergy testing market throughout the forecast period. As more healthcare providers and researchers recognize the advantages offered by this advanced technology, its widespread implementation will revolutionize the field of allergy diagnostics, leading to improved patient care and outcomes.

Key Market Players

• Abbott Laboratories Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Fluidigm Corporation
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Phalanx Biotech Group Inc.
• BioMerieux SA
• Qiagen NV

Report Scope:

In this report, the Global Biochip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biochip Market, By Technology:

• Microarray
• Microfluidics

Biochip Market, By Type:

• DNA Chips
• Lab-On-a-Chips
• Protein Chips
• Others

Biochip Market, By Application:

• Drug Discovery & Development
• Disease Diagnostics
• Genomics
• Proteomics
• In-vitro diagnostics
• Others

Biochip Market, By End User:

• Hospitals & Diagnostics Centres
• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
• Others

Biochip Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biochip Market.

Available Customizations:

Global Biochip market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biochip Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Microarray v/s Microfluidics)
  • 5.2.2. By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)
  • 5.2.3. By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics and Others)
  • 5.2.4. By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Biochip Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biochip Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Biochip Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Biochip Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Biochip Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biochip Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Biochip Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Biochip Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Biochip Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Biochip Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Biochip Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Biochip Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Biochip Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Biochip Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Biochip Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Biochip Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Biochip Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biochip Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Biochip Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Biochip Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Biochip Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biochip Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Biochip Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Biochip Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Products Launches

13. Global Biochip Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Agilent Technologies Inc.
• 15.3. Bio-Rad Laboratories Inc.
• 15.4. Fluidigm Corporation
• 15.5. Thermo Fisher Scientific Inc.
• 15.6. PerkinElmer Inc.
• 15.7. Illumina Inc.
• 15.8. Phalanx Biotech Group Inc.
• 15.9. BioMerieux SA
• 15.10. Qiagen NV

16. Strategic Recommendations

17. About Us & Disclaime